MedTrace Logo

Wingspan Stent System for Intracranial Artery Stenosis

NCT06618222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2025-04-23

No results posted yet for this study

Summary

The primary objective of this trial is to evaluate the safety and efficacy of Wingspan Stent System in \"real world\" patients with intracranial atherosclerotic stenosis.

Conditions

  • Intracranial Artery Stenosis
  • Stent
  • Endovascular Therapy

Interventions

DEVICE

Wingspan stent system

All patients had received Percutaneous transluminal angioplasty and stenting with Wingspan stent system.

Sponsors & Collaborators

  • The First People's Hospital of Changzhou

    lead OTHER

Principal Investigators

  • Ya Deng · The First People's Hospital of Changzhou

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2025-02-10
Completion
2025-02-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06618222 on ClinicalTrials.gov